| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025967 Zap protein and related compositions and methods |
| 02/01/2007 | US20070025966 With a sugar or polyethylene glycol; improved antiviral and immunomodulatory efficacy; HIV and hepatitis C vaccines |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | US20070025962 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070025911 Breast cancer; hybridomas; cell lines; kits |
| 02/01/2007 | DE10196565B4 Rekombinantes Human-Parathyroidhormon erzeugender Hefe-Transformant und Verfahren zur Herstellung des Hormons Recombinant human parathyroid hormone-producing yeast transformant and methods for producing the hormone |
| 02/01/2007 | CA2616789A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | CA2616099A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/01/2007 | CA2615983A1 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 02/01/2007 | CA2615532A1 Targeted integration and expression of exogenous nucleic acid sequences |
| 01/31/2007 | EP1748077A1 Method of producing protein |
| 01/31/2007 | EP1748073A1 Recombinant d-amino acid oxidase |
| 01/31/2007 | EP1748071A1 Process for producing polypeptide |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1747784A1 Target gene mimitin of myc |
| 01/31/2007 | EP1747280A2 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 01/31/2007 | EP1747279A2 Thrombomodulin derivatives and conjugates |
| 01/31/2007 | EP1747278A1 Method for producing cyclic peptides from in vitro plant cell cultures |
| 01/31/2007 | EP1747232A2 Molecules involved in protein folding and methods of identifying them |
| 01/31/2007 | EP1746985A2 Method for augmenting the effects of serotonin reuptake inhibitors |
| 01/31/2007 | EP1240519B1 Compositions and methods for detecting treponema pallidum |
| 01/31/2007 | CN1906307A Methods for purifying pertussis toxin and peptides useful therefor |
| 01/31/2007 | CN1906300A Novel serum type streptococcus mutans and ultilization of the same |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906296A Methods for the production of apolipoproteins in transgenic plants |
| 01/31/2007 | CN1906294A Improved protein expression systems |
| 01/31/2007 | CN1905899A EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/31/2007 | CN1904036A Method of producing three kinds of human alpha alexins by gene engineering bacteria mixed culture |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297316C Mutant forms of cholera holotoxin as adjuvant |
| 01/30/2007 | US7169989 Applying an enzyme for the selective removal of sub-unit parts of the polymer to at least one predetermined area of said polymeric substrate via a pipette with a nano-sized orifice |
| 01/30/2007 | US7169963 Transgenic swine which produce growth factors which facilitate piglet development and decrease mortality; veterinary medicine |
| 01/30/2007 | US7169915 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds |
| 01/30/2007 | US7169908 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
| 01/30/2007 | US7169906 Nucleotide sequences coding polypeptide for use in the treatment of skin and nervous system disorders |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169903 Killing gram positive bacteria in situ; vaccine |
| 01/30/2007 | US7169897 Adipocyte complement related protein ZACRP3X2 |
| 01/30/2007 | US7169896 Producing partially modified and partially hydrolysed fiberous protein; isolate feather, solubilize, incubate with reducing agent, recover protein; isolating fiberous protein from waste feathers for use in textile processing and supplementing cosmetics |
| 01/30/2007 | US7169893 Human HAC3 |
| 01/30/2007 | US7169891 Human pellino polypeptides |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169593 has both an alpha 2,3- and an alpha 2,8-activity; involved in synthesis of lipooligosaccharide (LOS); genetic engineering |
| 01/30/2007 | US7169589 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction |
| 01/30/2007 | US7169581 IL-18 receptors |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169567 Screening for an agonist or an antagonist of PTH receptor activity: |
| 01/30/2007 | US7169566 Metalloproteinases |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | US7169393 Antigenic peptide fragments of VapA protein, and uses thereof |
| 01/30/2007 | CA2351553C Transgenic animals |
| 01/30/2007 | CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2151123C Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 01/26/2007 | CA2553485A1 Multicopy-integration of heterologous genes and expression in methylobacterium |
| 01/25/2007 | WO2007011975A2 Methods to express recombinant proteins from lentiviral vectors |
| 01/25/2007 | WO2007011859A2 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | WO2007011392A2 Crystal structure of domain 111 of west nile virus envelope protein-fab fragment of neutralizing antibody complex |
| 01/25/2007 | WO2007011041A1 Genetically modified antibody composition |
| 01/25/2007 | WO2007010941A1 Antigen and monoclonal antibody capable of recognizing the antigen |
| 01/25/2007 | WO2007010651A1 Novel proteins and method of using the same |
| 01/25/2007 | WO2007009946A2 Process for the manufacture of eptifibatide |
| 01/25/2007 | WO2007009403A1 Growth-stimulating polypeptides for use in fish and crustaceans |
| 01/25/2007 | WO2007009351A1 A method of secretion expression of lysostaphin in escherichia coli at high level |
| 01/25/2007 | WO2006097708A3 Affinity purification of protein |
| 01/25/2007 | WO2006083927A3 Antimicrobial agent |
| 01/25/2007 | WO2006037048A3 Fc RECEPTOR HOMOLOG ANTIBODIES AND USES THEREOF |
| 01/25/2007 | WO2006028839A3 Delta 6-desaturase genes and uses thereof |
| 01/25/2007 | WO2006015165A3 Optimized interferon-beta gene |
| 01/25/2007 | WO2005113837A3 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 01/25/2007 | WO2005065019A3 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 01/25/2007 | WO2005019420A3 Chimeric receptors with disrupted dileucine motifs |
| 01/25/2007 | WO2005019415A3 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | US20070021600 Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics |
| 01/25/2007 | US20070021599 Comprises transport proteins diagnosis and treatment of cell proliferative disorders; antiproliferative agents; gene expression inhibition; detecting differential methylation patterns in the SLC5A8 gene which encode novel sodium solute symporter members |
| 01/25/2007 | US20070021597 Expressed sequence tags (EST); nucleotide sequence encoding signal peptide; vectors |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021595 Humanized antibody amd process for preparing same |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070021592 NPC1L1 (NPC3) and methods of use thereof |
| 01/25/2007 | US20070021589 Obesity-related genes |
| 01/25/2007 | US20070021364 Methods for genetic immunization |
| 01/25/2007 | US20070021361 Methods and materials for modulating trpm2 |
| 01/25/2007 | US20070020746 Staphylococcus aureus polynucleotides and sequences |
| 01/25/2007 | US20070020737 Hyaluronan synthases and methods of making and using same |
| 01/25/2007 | US20070020735 IL-17 homologous polypeptides and therapeutic uses thereof |
| 01/25/2007 | US20070020734 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections |
| 01/25/2007 | US20070020732 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens; signal transducer specifically expressed in human mast cells |
| 01/25/2007 | US20070020731 Thermostable amylase polypeptides, nucliec acids encoding those polypeptides and uses thereof |